PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
2125034-1	1990	We have studied the in vitro effects of gold sodium thiomalate (GST) and auranofin (Auf) on the production of interleukin 1 (IL1) expressed as thymocyte co-stimulatory activity (TCSA), and interleukin 1 beta (IL1 beta) as modulated by interferon gamma (IFN gamma).	Auranofin	73-82	interleukin 1 alpha	Homo sapiens	110-128	
1981242-8	1990	Gold compounds inhibited IL-1 activity, but only auranofin inhibited IL-1 production.	Auranofin	49-58	interleukin 1 alpha	Homo sapiens	69-73	
34072916-5	2021	However, auranofin significantly inhibited the levels of NO, monocyte chemoattractant protein-1, and pro-inflammatory cytokines, such as interleukin (IL)-1beta, tumor necrosis factor-alpha, and IL-6, which had been increased by co-treatment with PA and LPS.	Auranofin	9-18	interleukin 1 alpha	Homo sapiens	137-159	
34072916-6	2021	Moreover, the expression of inducible NO synthase, IL-1beta, and IL-6 mRNA and protein levels increased by PA and LPS were reduced by auranofin.	Auranofin	134-143	interleukin 1 alpha	Homo sapiens	51-59	
3142038-0	1988	Effect of auranofin and sodium aurothiomalate on interleukin-1 production from human monocytes in vitro.	Auranofin	10-19	interleukin 1 alpha	Homo sapiens	49-62	
32798556-4	2020	Auranofin (AFN), a Txnrd1 inhibitor, decreases IL-1beta levels and increases Nrf2 activation in lipopolysaccharide (LPS) treated alveolar macrophages.	Auranofin	0-9	interleukin 1 alpha	Homo sapiens	47-55	
32798556-4	2020	Auranofin (AFN), a Txnrd1 inhibitor, decreases IL-1beta levels and increases Nrf2 activation in lipopolysaccharide (LPS) treated alveolar macrophages.	Auranofin	11-14	interleukin 1 alpha	Homo sapiens	47-55